Delivery Order SPE2DB22D1106-SPE2DB25FFDA6
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,022.50 to AmerisourceBergen Drug Corp for the supply of Pregnyl 10,000 unit vials. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by August 20, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Pregnyl 10,000 unit vials, with a ceiling value of $1,813.50. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by August 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a competitively awarded transaction under AmerisourceBergen's existing contract...
- This delivery order, valued at $7,254.00, was awarded to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Pregnyl 10,000 unit vials. The contract is a firm fixed price delivery order with an ultimate completion date of August 11, 2025, and represents a child contract under a larger federal procurement vehicle. The award was made without a set-aside designation, indicating open competition. The place of performance is located in Conshohocken, Pennsylvania, the headquarters of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Pregnyl 10,000 Unit Vials, a human chorionic gonadotropin pharmaceutical product. This firm fixed-price delivery order, valued at $1,813.50, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999.00 through December 2026. The award was...
- The Defense Logistics Agency awarded a $2,418 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Pregnyl 10,000 unit vials, with an ultimate completion date of September 10, 2025. This non-set-aside contract was competitively awarded on September 9, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,489.70 firm-fixed-price contract is for the supply of PREGNYL 10,000 UNIT VIALS, a medical product, with a completion date of July 7, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which provides a...
- The Defense Logistics Agency awarded a delivery order valued at $3,627.00 to AmerisourceBergen Drug Corp for Pregnyl 10,000 unit vials, with performance completed by July 23, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively to the prime contractor. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,813.50 to AmerisourceBergen Drug Corp for Pregnyl 10,000 unit vials, a human chorionic gonadotropin medication. The contract is a firm fixed-price delivery order with an ultimate completion date of July 29, 2025, and represents a non-competitive set-aside award to the prime contractor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Pregnyl 10,000 Unit Vials with a ceiling value of $3,022.50. This is a firm fixed price delivery order with an ultimate completion date of July 21, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- The Defense Logistics Agency awarded a $2,418.00 delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for Pregnyl 10,000 unit vials, with an ultimate completion date of June 2, 2025. This non-set-aside, firm fixed price delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFDA6Delivery Order
This delivery order, valued at $2,418.00, awards Amerisourcebergen Drug Corp the supply of Pregnyl 10,000 unit vials for the Defense Logistics Agency. The contract is a firm fixed price delivery order with an ultimate completion date of August 14, 2025, and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation, reflecting the contractor's capability to meet federal procurement standards through open competition. This delivery order is issued under Amerisourcebergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. The IDC enables the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor serving federal medical procurement needs, Amerisourcebergen Drug Corp maintains an extensive portfolio of deliveries with the Defense Logistics Agency, fulfilling critical pharmaceutical requirements across multiple therapeutic domains for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 8/13/25 |